In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GSK and Verily Life Sciences form new joint venture Galvani Bioelectronics

Executive Summary

GlaxoSmithKline PLC and Verily Life Sciences LLC formed a new joint venture company Galvani Bioelectronics focusing on bioelectronic medicines. The two parent companies will contribute existing IP rights and invest up to £540mm ($702mm) over a seven-year term (subject to completion of discovery and development milestones).

Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
  • Biotechnology
    • Drug Discovery Technologies
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Joint Venture

Related Companies